Related Experiment Videos

New psychoactive substances: driving greater complexity into the drug problem

Michael Evans-Brown¹, Roumen Sedefov¹

¹European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.

Addiction (Abingdon, England)

|August 23, 2016

Summary

No abstract available in PubMed .

Keywords:

Early-warning systems counterfeit medicines fentanils globalization mass poisionings new psychoactive substances synthetic cannabinoids

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

In vitro activation of the CB1 receptor by the semi-synthetic cannabinoids hexahydrocannabinol (HHC), hexahydrocannabinol acetate (HHC-O) and hexahydrocannabiphorol (HHC-P).

Drug testing and analysis·2024

Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations.

European archives of psychiatry and clinical neuroscience·2024

DARK Classics in Chemical Neuroscience: Etonitazene and Related Benzimidazoles.

ACS chemical neuroscience·2021

Eutylone and Its Structural Isomers Interact with Monoamine Transporters and Induce Locomotor Stimulation.

ACS chemical neuroscience·2021

Will the Current COVID-19 Pandemic Impact on Long-term Cannabis Buying Practices?

Journal of addiction medicine·2020

New psychoactive substances: challenges for drug surveillance, control, and public health responses.

Lancet (London, England)·2019

See all related articles